Tag Archives: Pharmaceuticals

China Graves’ disease Market: Size, Share, Growth, Industry Analysis, Opportunities and Forecast 2019-2025

China Graves’ disease market is expected to grow at a CAGR of around 5.8% during the forecast period. Chinese Economy is growing considerably, and it has become a preferred destination for setting business due to cheap labor, improved infrastructure, and a large customer base. China’s market has both medium and long-term potential due to its large market size, aging population, fluctuating disease profile and rapidly improving life. The Chinese economy is becoming an R&D-intensive economy which is the major factor for the growth of the life science industry of China, and in turns affects China Graves’ disease market. Along with this, government support in the country is also affecting the growth of the market. The corporate tax rate in China is 16% as compared with other countries including India at around 35%. China has a large number of pharmaceutical and medical device companies as it is the manufacturing hub for pharmaceutical drugs base supplies.

Canada Graves’ Disease Market: ****** Size, Share, Industry Trends, Research and Forecast 2019-2025

Canada Graves’ disease market is growing at a CAGR of around 6.3% during the forecast period. Due to increasing awareness of thyroid disease in the country by various government organizations, the Canada Graves’ disease market is expected to grow. For instance, June is celebrated as thyroid awareness month in Canada. The Thyroid Foundation of Canada (TFC), a non-profit organization established in 1980 with the objective of supporting patients suffering from thyroid disease. The foundation has given nearly $1 million for researches on thyroid disease. This funding supports in researches on thyroid disease.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/canada-graves-disease-market

Rheumatoid Arthritis Therapeutics Market Share, Demand and Key Players by 2025

Rheumatoid Arthritis Therapeutics Market study is providing you with the up-to-date, actionable market information and projections with the latest impact of the Covid 19 outbreak. It offers all the requisite data to support tactical business decisions and come up with strategic growth plans. This study also proposes a comprehensive insight into the development policies and plans in addition to manufacturing processes and cost structures.

 

As per the study statement by the Grand View Research the ****** Rheumatoid Arthritis Therapeutics Market was appreciated by US$ 20.0 billion in 2016 and is estimated to stretch by a CAGR of 4.6% above the prediction period. Growing occurrence of stiffness, increasing recognition of biopharmaceuticals, and existence of distinct controlling rules in industrialized economies are between important tendencies estimated to generate the progress of the market.

Ophthalmic Therapeutics/Drugs Market Analysis, Share and Growth Rate to 2025

Ophthalmic Therapeutics/Drugs Market study is providing you with the up-to-date, actionable market information and projections with the latest impact of the Covid 19 outbreak. It offers all the requisite data to support tactical business decisions and come up with strategic growth plans. This study also proposes a comprehensive insight into the development policies and plans in addition to manufacturing processes and cost structures.

 

Thyroid Gland Disorder Treatment Market Analysis and Business Strategy Forecast 2025

Thyroid Gland Disorder Treatment Market study is providing you with the up-to-date, actionable market information and projections with the latest impact of the Covid 19 outbreak. It offers all the requisite data to support tactical business decisions and come up with strategic growth plans. This study also proposes a comprehensive insight into the development policies and plans in addition to manufacturing processes and cost structures.

 

Doxorubicin Market Size, In-Depth Analysis And Forecast By 2024

6th January 2020 – ****** Doxorubicin Market is expected to reach USD 1.38 billion by 2024. Doxorubicin is an anticancer chemotherapy drug, a generic name for the trade name drug Rubex® and Adriamycin®. It is injected into a vein. It is an essential medicine on the World Health Organization’s List, the safest and effective medicines needed in a health system. The Doxorubicin Market is estimated to grow at a significant CAGR of 6.4% over the forecast period as the scope and its applications are rising enormously across the globe.

 

Epilepsy Drugs Market Share, Product Segments and Growth Outlook Report By 2024

6th December 2019 – The ****** Epilepsy Drugs Market is anticipated to rise at a staggering CAGR in the forthcoming period. Epilepsy drugs have pharmacokinetic properties and are administered to children, adults, and adolescents. Carbamazepine is applicable for focal seizures with strong properties of inducing and enables development of milder tolerance level that could be increased weekly.

 

Epilepsy drugs market is highly driven by rise in cases of stroke, brain tumors, and brain injury. Antiepileptic drugs are prescribed due to the rising demands for treatment for epilepsy. Adoption of novel approach by manufacturers for production of therapeutic drugs also contributes to the market growth in the forecast period.

Erectile Dysfunction Drugs Market Trends and, Driving Factors Analysis Report 2022

4th December 2019 – The ****** Erectile Dysfunction Drugs Market size is expected to value at USD 3.2 billion by 2022. The market is subject to witness a substantial growth due to the rising health awareness among general population and increase in initiatives undertaken by local governments and private bodies to promote use of erectile dysfunction drugs. Growing education levels about use of these products coupled with rising geriatric population base across the globe is predicted to drive the growth of erectile dysfunction drugs industry over the forecast period. Changing food habits and adoption of sedentary lifestyle has led to prevalence of lifestyle diseases, thus propelling the demand for erectile dysfunction drugs in the market.

Astaxanthin Market Share, Top Key Players, Industry Analysis & Forecast By 2025

22nd October 2019 – ****** Astaxanthin Market is anticipated to reach USD 2.57 billion by 2025. Astaxanthin is also known as “The king of the Carotenoids”. It is a member of xanthophyll family of carotenoids. It is mainly found in marine animals and plants. In “Pacific sockeye salmon” the highest concentration of Astaxanthin is found. Algae, krill, lobster, crab, shrimp, and red trout also contain Astaxanthin. From Haematococcus Pluviailis (HP) commercial production astaxanthin is mainly obtained.

 

Gastrointestinal Therapeutics Market Shares, Strategies and Forecasts, Analysis and Overview to 2025

24th June 2019: ****** Gastrointestinal Therapeutics Market is anticipated to reach USD 65.1 billion by 2025. The market is anticipated to rise at a healthy growth rate in the years to come. Gastrointestinal disorders are medical situations associated with the digestive system that disturb the small & large intestine, colon, and rectum. The syndromes mostly comprise peptic ulcer diseases, irritable bowel syndrome and constipation, categorized by several symptoms and signs such as bloating, pain, diarrhea, vomiting, and nausea. Gastrointestinal therapeutics comprises medications, which are commercially accessible in the market namely Afinitor, Aciphex, Akynzeo, Prilosec and Dificid.